Defining cure for esophageal cancer: Analysis of actual 5-year survivors following esophagectomy

Annals of Surgical Oncology

Volumn 18, Issue 6, 2011, Pages 1766-1774

  Hirst, Jodi ^a   Smithers, Bernard Mark ^a   Gotley, David C ^a   Thomas, Janine ^b   Barbour, Andrew ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; TUMOR CLASSIFICATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; EPIRUBICIN; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; SURVIVORS; TREATMENT OUTCOME;

EID: 79956223031     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1508-z     Document Type: Article

References (30)

1. S Law DL Kwong KF Kwok KH Wong KM Chu JS Sham, et al. 2003 Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy Ann Surg. 238 339 347 14501500 discussion 347-8
2. HJ Stein BH von Rahden JR Siewert 2005 Survival after oesophagectomy for cancer of the oesophagus Langenbecks Arch Surg. 390 280 285 15252736 10.1007/s00423-004-0504-9 (Pubitemid 41110970)
3. W Hofstetter SG Swisher AM Correa K Hess JB Putnam Jr JA Ajani, et al. 2002 Treatment outcomes of resected esophageal cancer Ann Surg. 236 376 385 12192324 10.1097/00000658-200209000-00014 (Pubitemid 34971347)
4. H Pohl G Welch 2005 The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence J Natl Cancer Inst. 97 142 146 15657344 10.1093/jnci/dji024 (Pubitemid 40277094)
5. W Blot S Devesa R Kneller J Fraumeni 1991 Rising incidence of adenocarcinoma of the esophagus and gastric cardia JAMA. 265 1287 1289 1995976 10.1001/jama.265.10.1287 1:STN:280:DyaK3M7ktVOqsQ%3D%3D
6. A Jemal R Siegel E Ward 2007 Cancer statistics CA Cancer J Clin. 57 43 66 17237035 10.3322/canjclin.57.1.43
7. JA Hagen SR DeMeester JH Peters P Chandrasoma TR DeMeester 2001 Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies Ann Surg. 234 520 530 11573045 10.1097/00000658-200110000-00011 1:STN:280:DC%2BD3MrisFCqtQ%3D%3D discussion 530-1 (Pubitemid 32946714)
8. NK Altorki M Kent C Ferrara J Port 2002 Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus Ann Surg. 236 177 183 12170022 10.1097/00000658-200208000-00005 (Pubitemid 34809536)
9. A Watson 1994 Operable esophageal cancer: Current results from the West World J Surg. 18 361 366 8091776 10.1007/BF00316815 1:STN:280: DyaK2cznvVKgsw%3D%3D (Pubitemid 24215033)
10. G Portale JA Hagen JH Peters LS Chan SR DeMeester TA Gandamihardja, et al. 2006 Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients J Am Coll Surg. 202 588 596 16571425 10.1016/j.jamcollsurg.2005.12.022 discussion 596-8
11. JB Hulscher 2001 Transthoracic versus transhiatal resection for carcinoma of the esophagus: A meta-analysis Ann Thorac Surg. 72 306 313 11465217 10.1016/S0003-4975(00)02570-4 1:STN:280:DC%2BD3Mvhs1ejsw%3D%3D (Pubitemid 32643075)
12. M Tachibana S Kinugasa H Yoshimura M Shibakita Y Tonomoto DK Dhar, et al. 2005 Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma Am J Surg. 189 98 109 15701501 10.1016/j.amjsurg.2004.10.001 (Pubitemid 40215515)
13. Green FL, Page DL, Fleming ID. AJCC cancer staging manual. New York, NY: Springer-Verlag, 2002.
14. AP Barbour M Jones M Gonen DC Gotley J Thomas DB Thomson, et al. 2008 Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response Ann Surg Oncol. 15 2894 2902 18663531 10.1245/s10434-008- 0084-y
15. JR Siewert HJ Stein M Feith BLDM Bruecher H Bartels U Fink 2001 Histologic tumor type is an independent prognostic parameter in esophageal cancer: Lessons from more than 1000 consecutive resections at a single center in the Western world Ann Surg. 234 360 369 11524589 10.1097/00000658-200109000- 00010 1:STN:280:DC%2BD3MvotVylsQ%3D%3D (Pubitemid 32847073)
16. A Dubecz D Molena 2008 Peters, JH Modern surgery for esophageal cancer. Gastroenterol Clin North Am. 37 965 987 10.1016/j.gtc.2008.09.008
17. CG Peyre JA Hagen SR DeMeester NK Altorki E Ancona SM Griffin, et al. 2008 The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection Ann Surg. 248 549 556 18936567 10.1097/SLA.0b013e3181904f3c
18. JR Siewert M Feith M Werner HJ Stein 2000 Adenocarcinoma of the esophagogastric junction Ann Surg. 232 353 361 10.1097/00000658-200009000-00007
19. BM Smithers DC Gotley I Martin JM Thomas 2007 Comparison of the outcomes between open and minimally invasive esophagectomy Ann Surg 245 232 240 17245176 10.1097/01.sla.0000225093.58071.c6 (Pubitemid 46148482)
20. PC Wu MC Posner 2003 The role of surgery in the management of oesophageal cancer Lancet Oncol. 4 481 488 12901962 10.1016/S1470-2045(03)01167-7 (Pubitemid 37009956)
21. S Leibman BM Smithers DC Gotley I Martin J Thomas 2006 Minimally invasive esophagectomy: short- and long-term outcomes Surg Endosc. 20 428 433 16391954 10.1007/s00464-005-0388-y 1:STN:280:DC%2BD28%2FpsFGjtw%3D%3D (Pubitemid 43260501)
22. DN Sutton J Wayman SM Griffin 1998 Learning curve for oesophageal cancer surgery Br J Surg. 85 1399 1402 9782024 10.1046/j.1365-2168.1998.00962.x 1:STN:280:DyaK1cvltlartw%3D%3D (Pubitemid 28468346)
23. B Burmeister BM Smithers V Gebski 2006 Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial Lancet Oncol. 6 659 668 10.1016/S1470-2045(05)70288-6
24. KC Conlon MD Klimstra M Brennan 1996 Long-term survival after curative resection for pancreatic ductal adenocarcinoma Ann Surg. 223 273 279 8604907 10.1097/00000658-199603000-00007 1:STN:280:DyaK287pvFSgsQ%3D%3D (Pubitemid 26086718)
25. SN Hochwald S Kim MD Klimstra MF Brennan MS Karpeh 2000 Analysis of 154 actual five-year survivors of gastric cancer J Gastrointest Surg. 4 520 525 11077328 10.1016/S1091-255X(00)80095-5 1:STN:280:DC%2BD3M%2Fjslekug%3D%3D
26. SA Vorburger L Ubersax SW Schmid M Balli D Candinas CA Seiler 2009 Long-term follow-up after complete resection of well-differentiated cancer confined to the thyroid gland Ann Surg Oncol. 16 2862 2874 19655202 10.1245/s10434-009-0592-4
27. PI Karakiewicz C Jeldres N Suardi GC Hutterer P Perrotte U Capitanio, et al. 2008 Age at diagnosis is a determinant factor of renal cell carcinoma-specific survival in patients treated with nephrectomy Can Urol Assoc J. 2 610 617 19066680
28. DW Zhang GY Cheng GJ Huang RG Zhang XY Liu YS Mao, et al. 1994 Operable squamous esophageal cancer: current results from the East World J Surg. 18 347 354 8091774 10.1007/BF00316813 1:STN:280:DyaK2cznvVKhuw%3D%3D (Pubitemid 24215031)
29. M Omundsen R Babor P Johnston 2007 Outcomes after oesophagogastrectomy for carcinoma of the oesophagus ANZ J Surg. 77 37 39 17295818 10.1111/j.1445-2197.2006.03973.x (Pubitemid 46145620)
30. J Tomlinson W Jarnagin R DeMatteo Y Fong P Kornprat M Gonen, et al. 2007 Actual 10-year survival after resection of colorectal liver metastases defines cure J Clin Oncol. 25 4575 4580 17925551 10.1200/JCO.2007.11.0833 (Pubitemid 350035315)